Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease
- PMID: 3038438
- PMCID: PMC1542599
Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease
Abstract
Modification of beta-2-microglobulin has been shown to occur in vitro in serum of patients suffering of small cell lung cancer, where it clearly correlated to the clinical course of disease. The cause of serum beta-2-microglobulin modification occurring in these patients is investigated in the present study. This revealed that modification of beta-2-microglobulin is due to cleavage by a serine protease, which is dependent on divalent cations and has a trypsin-like specificity. The process showed the following characteristics: pH optimum at 8.5, heat inactivation by incubation at 56 degrees C for 20 min and temperature optimum at 20 degrees C.
Similar articles
-
A method to detect the in vitro modification of serum beta-2-microglobulin in health and disease.Clin Chim Acta. 1988 Sep 30;177(1):89-99. doi: 10.1016/0009-8981(88)90311-7. Clin Chim Acta. 1988. PMID: 2846212
-
[Beta-2-microglobulin in bronchogenic carcinoma].Sb Lek. 1990 Nov-Dec;92(11-12):366-9. Sb Lek. 1990. PMID: 2136432 Czech.
-
Modification of beta 2-microglobulin in serum from patients with small cell carcinoma of the lung--correlation with the clinical course.Clin Chim Acta. 1984 Aug 15;141(1):41-50. doi: 10.1016/0009-8981(84)90165-7. Clin Chim Acta. 1984. PMID: 6088125
-
Solubilization of full-length amyloid precursor proteins from PC12 cell membranes.J Neurosci Res. 1994 Oct 1;39(2):211-8. doi: 10.1002/jnr.490390211. J Neurosci Res. 1994. PMID: 7530778
-
Early stages of misfolding and association of beta2-microglobulin: insights from infrared spectroscopy and dynamic light scattering.Biochemistry. 2008 Jul 1;47(26):6895-906. doi: 10.1021/bi800279y. Epub 2008 Jun 10. Biochemistry. 2008. PMID: 18540682
Cited by
-
B2M overexpression correlates with malignancy and immune signatures in human gliomas.Sci Rep. 2021 Mar 3;11(1):5045. doi: 10.1038/s41598-021-84465-6. Sci Rep. 2021. PMID: 33658560 Free PMC article.
-
Primary Gastric Diffuse Large B-Cell Lymphoma: Prognostic Factors in the Immuno-Oncology Therapeutics Era.Turk J Haematol. 2020 Aug 28;37(3):193-202. doi: 10.4274/tjh.galenos.2020.2019.0332. Epub 2020 Mar 12. Turk J Haematol. 2020. PMID: 32160735 Free PMC article.
-
Excess-substrate inhibition in enzymology and high-dose inhibition in pharmacology: a reinterpretation [corrected].Biochem J. 1994 Feb 15;298 ( Pt 1)(Pt 1):171-80. doi: 10.1042/bj2980171. Biochem J. 1994. PMID: 8129717 Free PMC article.
-
Strategy for degradomic-peptidomic analysis of human blood plasma.J Proteome Res. 2010 May 7;9(5):2339-46. doi: 10.1021/pr901083m. J Proteome Res. 2010. PMID: 20377236 Free PMC article.
-
Novel prognostic scoring system for diffuse large B-cell lymphoma.Oncol Lett. 2018 Apr;15(4):5325-5332. doi: 10.3892/ol.2018.7966. Epub 2018 Feb 6. Oncol Lett. 2018. PMID: 29552174 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials